Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Marko Hawlina, SOE 2019 – Golden Apple Award

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 15th 2019

Marko Hawlina was the 2019 recipient of the Golden Apple Award for education and leadership at SOE 2019. We caught up with him at the congress to talk about educating ophthalmologists, the importance of strong leadership and the innovations he has introduced that contributed to the Golden Apple Award.

Questions:
1. How has education changed for ophthalmologists over the past few years?
2. What innovations have you introduced to assist with education?
3. How important is strong leadership in achieving education goals?
4. What advice would you give to young ophthalmologists around continuing education?
5. Please tell us a bit about the Golden Apple Award?

Filmed in partnership with the European Society of Ophthalmology (SOE) at the SOE 2019 meeting in Nice, France.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup